Safety and immune response study of V4020 vaccine in healthy adults
Part of Brain & nervous system, Infections clinical trials.
This study tests a new vaccine called V4020 designed to protect against Venezuelan equine encephalitis (VEE), a virus spread by mosquitoes. The vaccine is given to healthy adults to see if it is safe and creates a good immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 50 years old.
- You have not had a VEE vaccine or VEE virus exposure before.
- You do not have diabetes or a close family member with diabetes.
- You are not currently taking medications that suppress your immune system (like steroids or chemotherapy).
- You are willing to avoid mosquito bites and not donate blood or organs for one year after the vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a VEE (Venezuelan equine encephalitis) booster vaccine is safe and helps your immune system respond in adults. It is for people previously vaccinated with VEE TC-83 who currently have low immune protection.
This study tests how safe a Rift Valley fever (RVF) vaccine is and how strongly it triggers the body’s immune response. You may be eligible if you are at risk of RVF exposure and your blood test shows you don’t already have strong protection.
This study tests a new experimental vaccine designed to protect against Sudan virus, a rare but serious disease. Researchers will check if the vaccine is safe and helps your immune system fight off the virus.
This study tests two experimental mRNA-based HIV vaccines to see if they are safe and create an immune response. It is for healthy adults aged 18 to 55 who do not have HIV.
This study tests a new vaccine designed to protect against Epstein-Barr virus (EBV), a common virus that can cause serious illness. You would receive the vaccine and be monitored to see how safe it is and how your immune system responds.
This study tests an experimental HIV vaccine that uses tiny particles and mRNA technology in healthy adults. If you qualify, you'll help researchers see if it's safe and if it triggers an immune response.
Hear when a new Venezuelan Equine Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.